Codexis, Inc. (CDXS)
Dopo ore:
| Chiusura precedente | 6,48 |
| Aperto | 6,41 |
| Denaro | 6,50 x 1100 |
| Lettera | 6,90 x 1000 |
| Min-Max giorno | 6,37 - 6,72 |
| Intervallo di 52 settimane | 4,21 - 22,22 |
| Volume | |
| Media Volume | 826.898 |
| Capitalizzazione | 431,564M |
| Beta (5 anni mensile) | 1,48 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,32 |
| Prossima data utili | 22 feb 2023 - 27 feb 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 14,25 |
- GlobeNewswire
Codexis Announces Appointment of Sri Ryali as Chief Financial Officer
REDWOOD CITY, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Sri Ryali as Chief Financial Officer effective immediately. Mr. Ryali brings 20 years of finance and commercial experience in life sciences to Codexis. In this role, Mr. Ryali will lead all aspects of the Company’s financial operations and will report directly to Dr. Stephen Dilly, President and Chief Executive Officer of Codexis. “I am ex
- GlobeNewswire
Codexis Announces Appointment of H. Stewart Parker to Board of Directors
REDWOOD CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of H. Stewart Parker to its Board of Directors. “Stewart’s deep expertise in gene therapy and demonstrated track record of executive leadership within the biopharmaceutical industry make her a compelling addition as we seek to continue to strengthen the diversity of our Board with a breadth of professional experience, educational background,
- GlobeNewswire
Codexis Provides Update on Prioritized Corporate Strategy
REDWOOD CITY, Calif., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced an update on the Company’s ongoing plan to prioritize its time and resources on areas where the Company believes it has the strongest commercial opportunity and greatest probability of success. As part of this plan, the Company has decided to discontinue investment in certain internal development programs, expand investment in high potential development prog
